Dong Kun Lee

Dong Kun Lee

Auto-generated profile, based on publicly available information

Dong Kun Lee

Department of Otorhinolaryngology-Head and Neck Surgery, Dong-A University College of Medicine, Busan, Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2013 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
SCSun Yi Choi
Sun Yi Choi
HPHeonSoo Park
HeonSoo Park
MKMyung Koo Kang
Myung Koo Kang
DLDong Kun Lee
Dong Kun Lee
KLKang Dae Lee
Kang Dae Lee
JHJong Chul Hong
Jong Chul Hong
The BRAFV600E mutation, which accounts for about 60–80% papillary thyroid carcinoma(PTC), has been identifiedas a prognostic marker for risk stratification of PTC patients. However, the BRAFV600E mutation as a prognostic marker in papillary thyroid microcarcinoma (PTMC) is unclear. We performed a retrospective review of 101 patients who underwent surgery for PTMC. We studied the prevalence of the BRAFV600E mutation. The associations between the BRAFV600E mutation and clinicopathologic characteristics were analyzed. The BRAFV600E mutation was observed in 72 patients (71.3%). There was no statistically significant correlation in age, gender, multifocality, extrathyroidal extension, presence of Hashimoto thyroiditis, and lymph node metastasis between the BRAFV600E mutant group and wild group. The BRAFV600E mutation is not significantly associated with prognostic factors in PTMC.

1 February 2022 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
PLPhoniatrics And Logopedics Guideline Task Force Korean Society Of Laryngology
Phoniatrics And Logopedics Guideline Task Force Korean Society Of Laryngology
CRChang Hwan Ryu
Chang Hwan Ryu
SLSeung Jin Lee
Seung Jin Lee
JCJae-Gu Cho
Jae-Gu Cho
ICIk Joon Choi
Ik Joon Choi
JLJae-Yol Lim
Jae-Yol Lim
Voice change is a common complaint after thyroid surgery and has a significant impact on quality of life. The Korean Society of Laryngology, Phoniatrics and Logopedics assembled a task force to establish guideline recommendations on education, care, and management related to thyroid surgery. The guideline recommendations encompass preoperative voice education, management of anticipated voice change during surgery, and comprehensive voice care after thyroid surgery, and include in-depth information and up-to-date knowledge based on validated literature. The committee constructed 14 key questions (KQs) in three categories—preoperative (KQ 1–2), intraoperative (KQ 3–8), and postoperative (KQ 9–14) management—and developed 18 evidence-based recommendations. The Delphi survey reached an agreement on each recommendation. A detailed evidence profile is presented for each recommendation. The level of evidence for each recommendation was classified as high-quality, moderate-quality, or low-quality. The strength of each recommendation was designated as strong or weak considering the level of evidence supporting the recommendation. The guidelines are primarily targeted toward physicians who treat thyroid surgery patients and speech-language pathologists participating in patient care. These guidelines will also help primary care physicians, nurses, healthcare policymakers, and patients improve their understanding of voice changes and voice care after thyroid surgery.

1 January 2016 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
JPJun-Ook Park
Jun-Ook Park
MKMi-Ra Kim
Mi-Ra Kim
DKDo Hun Kim
Do Hun Kim
DLDong Kun Lee
Dong Kun Lee
Park JO, et al. Ann Surg Treat Res. 2016 Nov;91(5):269-272. https://doi.org/10.4174/astr.2016.91.5.269

21 July 2014 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Closed access
DLDong Kun Lee
Dong Kun Lee
JSJi Won Seo
Ji Won Seo
HPHeon Soo Park
Heon Soo Park
MKMyung Koo Kang
Myung Koo Kang
AJAe Lan Jang
Ae Lan Jang
JHJong Chul Hong
Jong Chul Hong
Ethanol ablation has been known as an effective, easy, and safe treatment of cystic thyroid lesions. The objective of the present study was to evaluate efficacy of ethanol ablation as a minimally invasive management of thyroglossal duct cyst (TGDC). Between January 2012 and July 2013, 9 TGDC patients were diagnosed and treated with ethanol ablation. We evaluated the treatment outcomes with the change of volume reduction and the improvement of symptomatic and cosmetic complaints and complications. Initial mean tumor volume was 8.9 mL (range, 0.2-36.9 mL) in ultrasonography. The mean number of the treatment sessions was 1.7 (range, 1-3 sessions). At last follow-up, the mean volume of the treated thyroglossal duct cyst decreased significantly from 8.9 mL to 1.9 mL (P = .019; volume reduction rate = 76.6%). Treatment success rate was 77.8% (7/9). Mean symptoms and cosmetic-grading scores improved from 5.2 to 3.1 and from 5.3 to 3.1 (P = .062). No significant complications were observed during follow-up. Ethanol ablation is a feasible and convenient procedure without surgical scars and hospitalization for TGDC patients. Favorable outcomes can be achieved without significant complications.

28 February 2023 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
JPJun-Ook Park
Jun-Ook Park
JKJOO HYUN KIM
JOO HYUN KIM
YJYoung Hoon Joo
Young Hoon Joo
SKSang-Yeon Kim
Sang-Yeon Kim
GKGeun-Jeon Kim
Geun-Jeon Kim
SKSoon-Young Kwon
Soon-Young Kwon
The aim of this study was to develop evidence-based recommendations for determining the surgical extent in patients with locally invasive differentiated thyroid cancer (DTC). Locally invasive DTC with gross extrathyroidal extension invading surrounding anatomical structures may lead to several functional deficits and poor oncological outcomes. At present, the optimal extent of surgery in locally invasive DTC remains a matter of debate, and there are no adequate guidelines. On October 8, 2021, four experts searched the PubMed, Embase, and Cochrane Library databases; the identified papers were reviewed by 39 experts in thyroid and head and neck surgery. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach was used to assess the quality of evidence, and to develop and report recommendations. The strength of a recommendation reflects the confidence of a guideline panel that the desirable effects of an intervention outweigh any undesirable effects, across all patients for whom the recommendation is applicable. After completing the draft guidelines, Delphi questionnaires were completed by members of the Korean Society of Head and Neck Surgery. Twenty-seven evidence-based recommendations were made for several factors, including the preoperative workup; surgical extent of thyroidectomy; surgery for cancer invading the strap muscles, recurrent laryngeal nerve, laryngeal framework, trachea, or esophagus; and surgery for patients with central and lateral cervical lymph node involvement. Evidence-based guidelines were devised to help clinicians make safer and more efficient clinical decisions for the optimal surgical treatment of patients with locally invasive DTC.

30 November 2023 in Clinical and Experimental Otorhinolaryngology
Verified
Journal Article
Open access
PDF file
MBMyung Jin Ban
Myung Jin Ban
CRChang Hwan Ryu
Chang Hwan Ryu
JWJoo Hyun Woo
Joo Hyun Woo
YLYoung Chan Lee
Young Chan Lee
DLDong Kun Lee
Dong Kun Lee
SLSeung Won Lee
Seung Won Lee
The Korean Society of Laryngology, Phoniatrics and Logopedics created a task force to establish clinical practice guidelines for the use of botulinum toxin (BT) in otolaryngology. We selected 10 disease categories: spasmodic dysphonia, essential vocal tremor, vocal fold granuloma, bilateral vocal fold paralysis, Frey’s syndrome, sialocele, sialorrhea, cricopharyngeal dysfunction, chronic sialadenitis, and first bite syndrome. To retrieve all relevant papers, we searched the CORE databases with predefined search strategies, including Medline (PubMed), Embase, the Cochrane Library, and KoreaMed. The committee reported 13 final recommendations with detailed evidence profiles. The guidelines are primarily aimed at all clinicians applying BT to the head and neck area. In addition, the guidelines aim to promote an improved understanding of the safe and effective use of BT by policymakers and counselors, as well as in patients scheduled to receive BT injections.